Yuki Matsushima Selected Research

Yuki Matsushima Research Topics

Disease

5	Infections 10/2023 - 01/2014
5	Inflammation (Inflammations) 01/2015 - 08/2009
3	Arthritis (Polyarthritis) 09/2016 - 01/2013
2	Reinfection 01/2020 - 01/2019
2	Respiratory Hypersensitivity 01/2015 - 04/2012
2	Asthma (Bronchial Asthma) 01/2015 - 04/2012
2	Fibrosis (Cirrhosis) 02/2013 - 01/2013
2	Contact Dermatitis (Eczema, Contact) 10/2011 - 08/2009
1	Persistent Infection 10/2023
1	Cysts 11/2017
1	Respiratory Tract Infections (Respiratory Tract Infection) 02/2017
1	Paramyxoviridae Infections (Parainfluenza) 02/2017
1	Major Depressive Disorder (Major Depressive Disorders) 01/2017
1	Foodborne Diseases 01/2017
1	Neoplasms (Cancer) 02/2016
1	Virus Diseases (Viral Diseases) 01/2016
1	Hypersensitivity (Allergy) 01/2015
1	Rhinitis 01/2015
1	Disease Progression 01/2015
1	Acute Lung Injury 10/2013
1	Rheumatoid Arthritis 01/2013
1	Autoimmune Diseases (Autoimmune Disease) 01/2013
1	Neuralgia (Stump Neuralgia) 06/2011
1	Hyperalgesia 06/2011
1	Vomiting 12/2008
1	Catalepsy 12/2008
1	Hallucinations (Hallucination) 12/2008

Drug/Important Bio-Agent (IBA)

3	EpitopesIBA 01/2020 - 01/2017
3	Proteins (Proteins, Gene)FDA Link 01/2019 - 01/2016
3	Peptides (Polypeptides)IBA 09/2016 - 01/2013
3	Glucose-6-Phosphate Isomerase (Phosphoglucose Isomerase)IBA 09/2016 - 01/2013
3	Fingolimod Hydrochloride (FTY720)FDA Link 09/2016 - 01/2013
2	AntibodiesIBA 12/2018 - 01/2014
2	AntigensIBA 09/2016 - 01/2015
2	OvalbuminIBA 01/2015 - 04/2012
2	Immunoglobulin E (IgE)IBA 01/2015 - 10/2011
2	CytokinesIBA 01/2015 - 04/2012
2	Complement System Proteins (Complement)IBA 10/2013 - 04/2012
2	Carboxypeptidase B2 (Thrombin Activatable Fibrinolysis Inhibitor)IBA 10/2013 - 04/2012
2	Therapeutic UsesIBA 01/2013 - 08/2009
1	RNA (Ribonucleic Acid)IBA 10/2023
1	Antiviral Agents (Antivirals)IBA 10/2023
1	Neutralizing AntibodiesIBA 01/2019
1	B-Lymphocyte Epitopes (B-Cell Epitope)IBA 01/2017
1	Palivizumab FDA Link 01/2017
1	Antidepressive Agents (Antidepressants)IBA 01/2017
1	DNA (Deoxyribonucleic Acid)IBA 01/2017
1	brexpiprazoleIBA 01/2017
1	Combined Antibody TherapeuticsIBA 02/2016
1	Capsid Proteins (Capsid Protein)IBA 01/2016
1	Protein CIBA 01/2015
1	Bleomycin (Blenoxane)FDA LinkGeneric 02/2013
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2013
1	Small Interfering RNA (siRNA)IBA 01/2013
1	AutoantigensIBA 01/2013
1	OsteopontinIBA 04/2012
1	Interleukin-5 (Interleukin 5)IBA 04/2012
1	ProstaglandinsIBA 10/2011
1	Prostaglandin D2IBA 10/2011
1	prostaglandin D2 receptorIBA 10/2011
1	Aminobutyrates (Aminobutyric Acid)IBA 06/2011
1	gamma-Aminobutyric Acid (GABA)IBA 06/2011
1	LigandsIBA 08/2009
1	Opioid Analgesics (Opioids)IBA 12/2008
1	Dopamine AntagonistsIBA 12/2008
1	Aripiprazole (Abilify)FDA Link 12/2008
1	Prochlorperazine (Compazine)FDA LinkGeneric 12/2008

Therapy/Procedure

2	Therapeutics 01/2017 - 01/2016
1	Tooth Extraction (Tooth Extractions) 11/2017
1	Remission Induction 01/2013
1	Ligation 06/2011